Fecal Calprotectin: A Reliable Predictor of Mucosal Healing after Treatment for Active Ulcerative Colitis
Objectives. Mucosal healing has become the new goal of treatment in ulcerative colitis. Fecal calprotectin has been demonstrated to differentiate between mucosal inflammation and mucosal healing. With this project, we investigated whether a reduction in f-calprotectin to <250 μg/g after medical t...
Saved in:
Main Authors: | Vendel Kristensen, Arne Røseth, Tahir Ahmad, Viggo Skar, Bjørn Moum |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2017/2098293 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Systematic Review with Meta-Analysis: Fecal Calprotectin as a Surrogate Marker for Predicting Relapse in Adults with Ulcerative Colitis
by: Jiajia Li, et al.
Published: (2019-01-01) -
Estimation of salivary IL-6 and calprotectin in patients with ulcerative colitis
by: Fadhel A. Abdullah, et al.
Published: (2024-12-01) -
Clinical Study of the Relation between Mucosal Healing and
Long-Term Outcomes in Ulcerative Colitis
by: Kaoru Yokoyama, et al.
Published: (2013-01-01) -
Fecal microbiome change in patients with ulcerative colitis after fecal microbiota transplantation
by: A. Y. Tikunov, et al.
Published: (2020-04-01) -
Fecal Calprotectin Use in Inflammatory Bowel Disease and Beyond: A Mini-Review
by: Bashaar Alibrahim, et al.
Published: (2015-01-01)